VRTX vs DXCM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DXCM Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DexCom, Inc. (DXCM) driven by superior Valuation, Momentum & Technical, Options & Structure while VRTX counters with relative strength in Growth & Margin. Fundamentally, VRTX trades at 25.9x Forward P/E with 37.8% operating margin (+11.8% YoY revenue) versus DXCM at 25.3x Forward P/E and 24.0% operating margin (+11.2% YoY). In options structure, VRTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro) against DXCM sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VRTX Revenue | DXCM Revenue | VRTX Op. Margin | DXCM Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $3.05B | $1.03B | 20.8% | -18.1% | VRTX |
| FY2019 | $4.16B | $1.48B | 28.8% | 9.6% | VRTX |
| FY2020 | $6.21B | $1.93B | 46.0% | 15.5% | VRTX |
| FY2021 | $7.57B | $2.45B | 36.7% | 10.9% | VRTX |
| FY2022 | $8.93B | $2.91B | 48.2% | 13.4% | VRTX |
| FY2023 | $9.87B | $3.62B | 38.8% | 16.5% | VRTX |
| FY2024 | $11.0B | $4.03B | -2.1% | 14.9% | DXCM |
| FY2025 | $12.0B | $4.66B | 34.8% | 19.6% | VRTX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VRTX | DXCM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $132.0B | $29.9B | Larger Scale | VRTX |
| Trailing P/E Ratio Valuation | 33.5x | 31.6x | Lower Multiple | DXCM |
| Forward P/E Ratio Valuation | 25.9x | 25.3x | Lower Multiple | DXCM |
| Revenue Growth (YoY) Growth | +11.8% | +11.2% | Higher Growth | VRTX |
| Operating Margin (TTM) Profitability | 37.8% | 24.0% | Higher Margin | VRTX |
| Net Profit Margin Profitability | 30.7% | 19.4% | Higher Margin | VRTX |
| Return on Equity (ROE) Capital Efficiency | 20.8% | 37.7% | Higher ROE | DXCM |
| 52-Week Range Position Momentum | 66% ($412โ$569) | 63% ($57โ$93) | Stronger Trend | VRTX |
| Beta / 30D Volatility Risk Regime | 0.35ฮฒ ยท 28% Vol | 0.59ฮฒ ยท 43% Vol | Lower Realized Risk | VRTX |
| Unified Institutional Score Composite Signal | 40.9 / 100 (SELL) | 50.8 / 100 (HOLD) | Higher Composite | DXCM |